Tylosin

Tylosin is a lipid of Polyketides (PK) class. Tylosin is associated with abnormalities such as Mastitis, Bovine, Infection, Bacterial Infections, Arthritis and Ileitis. The involved functions are known as Anabolism, acireductone dioxygenase [iron(II)-requiring] activity, Protein Biosynthesis, Mastitis and Methylation. Tylosin often locates in Ribosomes, Cell Wall, 50S ribosomal subunit, Ribosome Subunits, Large and Ribosome Subunits. The associated genes with Tylosin are Gene Clusters, Genome, resistance genes, Homologous Gene and HM13 gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Tylosin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tylosin?

Tylosin is suspected in Porcine ulcerative spirochetosis, Infection, Liver Abscess, Respiration Disorders, Intestinal Diseases, Mastitis, Bovine and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tylosin

MeSH term MeSH ID Detail
Digital Dermatitis D058066 3 associated lipids
Bovine Respiratory Disease Complex D048090 2 associated lipids
Pneumonia of Calves, Enzootic D048089 2 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Pneumonia of Swine, Mycoplasmal D045729 2 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Primate Diseases D018419 2 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Bacillaceae Infections D016863 1 associated lipids
Mycotoxicosis D015651 5 associated lipids
Weight Gain D015430 101 associated lipids
Vasculitis D014657 14 associated lipids
Treponemal Infections D014211 3 associated lipids
Tracheal Diseases D014133 3 associated lipids
Swine Diseases D013553 16 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Pasteurellosis, Pneumonic D012766 3 associated lipids
Pyoderma D011711 5 associated lipids
Poultry Diseases D011201 21 associated lipids
Pneumonia, Mycoplasma D011019 6 associated lipids
Pasteurella Infections D010326 8 associated lipids
Occupational Diseases D009784 42 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Lymphadenitis D008199 8 associated lipids
Liver Abscess D008100 6 associated lipids
Keratoconjunctivitis, Infectious D007639 2 associated lipids
Hyperplasia D006965 34 associated lipids
Hemolysis D006461 131 associated lipids
Foreign Bodies D005547 5 associated lipids
Facial Dermatoses D005148 7 associated lipids
Erysipelothrix Infections D004889 1 associated lipids
Enterotoxemia D004767 1 associated lipids
Dysentery D004403 4 associated lipids
Diarrhea D003967 32 associated lipids
Conjunctivitis, Viral D003236 1 associated lipids
Colitis D003092 69 associated lipids
Clostridium Infections D003015 5 associated lipids
Cattle Diseases D002418 24 associated lipids
Campylobacter Infections D002169 13 associated lipids
Body Weight D001835 333 associated lipids
Bacteriuria D001437 7 associated lipids
Bacterial Infections D001424 21 associated lipids
Ataxia D001259 20 associated lipids
Asthma D001249 52 associated lipids
Per page 10 20 50 | Total 47

PubChem Associated disorders and diseases

What pathways are associated with Tylosin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tylosin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tylosin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tylosin?

There are no associated biomedical information in the current reference collection.

What genes are associated with Tylosin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tylosin?

Knock-out

Knock-out are used in the study 'A second tylosin resistance determinant, Erm B, in Arcanobacterium pyogenes.' (Jost BH et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tylosin

Download all related citations
Per page 10 20 50 100 | Total 931
Authors Title Published Journal PubMed Link
Mutak S et al. Semisynthetic macrolide antibacterials derived from tylosin. Synthesis and structure-activity relationships of novel desmycosin analogues. 2004 J. Med. Chem. pmid:14711312
McFarland JW et al. Repromicin derivatives with potent antibacterial activity against Pasteurella multocida. 1997 J. Med. Chem. pmid:9083494
de Zwart MA et al. Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines. 1989 J. Med. Chem. pmid:2913309
Nowakiewicz A et al. Determination of antimicrobial resistance of Enterococcus strains isolated from pigs and their genotypic characterization by method of amplification of DNA fragments surrounding rare restriction sites (ADSRRS fingerprinting). 2017 J. Med. Microbiol. pmid:28260584
Karlsson M et al. Further characterization of porcine Brachyspira hyodysenteriae isolates with decreased susceptibility to tiamulin. 2004 J. Med. Microbiol. pmid:15017283
Kim J et al. Effects of the Antibiotics Growth Promoter Tylosin on Swine Gut Microbiota. 2016 J. Microbiol. Biotechnol. pmid:26869601
Cundliffe E Control of tylosin biosynthesis in Streptomyces fradiae. 2008 J. Microbiol. Biotechnol. pmid:18852501
Han AR et al. Biosynthesis of glycosylated derivatives of tylosin in Streptomyces venezuelae. 2011 J. Microbiol. Biotechnol. pmid:21715968
Choi D et al. Tylosin production by Streptomyces fradiae using raw cornmeal in airlift bioreactor. 2007 J. Microbiol. Biotechnol. pmid:18051315
Douthwaite S et al. Interaction of the tylosin-resistance methyltransferase RlmA II at its rRNA target differs from the orthologue RlmA I. 2008 J. Mol. Biol. pmid:18406425
Douthwaite S et al. The tylosin-resistance methyltransferase RlmA(II) (TlrB) modifies the N-1 position of 23S rRNA nucleotide G748. 2004 J. Mol. Biol. pmid:15046978
Poulsen SM et al. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. 2000 J. Mol. Biol. pmid:11090288
Petropoulos AD et al. Time-resolved binding of azithromycin to Escherichia coli ribosomes. 2009 J. Mol. Biol. pmid:19071138
Kim E et al. Characterization of the Two Methylation Steps Involved in the Biosynthesis of Mycinose in Tylosin. 2016 J. Nat. Prod. pmid:27453999
Herd MB et al. Extrasynaptic GABA(A) receptors couple presynaptic activity to postsynaptic inhibition in the somatosensory thalamus. 2013 J. Neurosci. pmid:24027285
Nakura H et al. Formation of an antibacterial metabolite from a new macrolide compound 23-O-benzyl-5-mycaminosyl-tylonolide (TMC-101), by a hepatic microsomal drug-metabolizing enzyme system. 1991 J. Pharmacobio-dyn. pmid:1802985
Von Essen S et al. Unintentional human exposure to tilmicosin (Micotil 300). 2003 J. Toxicol. Clin. Toxicol. pmid:12807303
Shryock TR et al. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease. 2002 J. Vet. Diagn. Invest. pmid:12296390
DeRosa DC et al. In vitro susceptibility of porcine respiratory pathogens to tilmicosin. 2000 J. Vet. Diagn. Invest. pmid:11108454
Harvey RB et al. Influence of the antibiotics lincomycin and tylosin on aflatoxicosis when added to aflatoxin-contaminated diets of growing swine. 1995 J. Vet. Diagn. Invest. pmid:7578454
Shryock TR et al. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. 1996 J. Vet. Diagn. Invest. pmid:8844577
Westermarck E et al. Tylosin-responsive chronic diarrhea in dogs. 2005 Mar-Apr J. Vet. Intern. Med. pmid:15822561
German AJ et al. Comparison of direct and indirect tests for small intestinal bacterial overgrowth and antibiotic-responsive diarrhea in dogs. 2003 Jan-Feb J. Vet. Intern. Med. pmid:12564725
Westermarck E et al. Effect of diet and tylosin on chronic diarrhea in beagles. 2005 Nov-Dec J. Vet. Intern. Med. pmid:16355675
Mateusen B et al. A comparative study of the preventive use of tilmicosin phosphate (Pulmotil premix) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. 2001 J. Vet. Med. B Infect. Dis. Vet. Public Health pmid:11846018
Hoflack G et al. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs. 2001 J. Vet. Med. B Infect. Dis. Vet. Public Health pmid:11765801
Altunok V et al. Investigation of haematological and biochemical side effects of tilmicosin in healthy New Zealand rabbits. 2002 J. Vet. Med. B Infect. Dis. Vet. Public Health pmid:12002421
Yazar E et al. The effect of tilmicosin on cardiac superoxide dismutase and glutathione peroxidase activities. 2002 J. Vet. Med. B Infect. Dis. Vet. Public Health pmid:12069277
Prapasarakul N et al. In vitro susceptibility and a new point mutation associated with tylosin-resistance in Japanese canine intestinal spirochetes. 2003 J. Vet. Med. Sci. pmid:14709813
Kim EY et al. Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs. 2011 J. Vet. Med. Sci. pmid:21068517
Katoh T et al. The fractional inhibitory concentration index of antimicrobial agents for bacteria and Mycoplasma isolated from the nasal swabs of cattle with respiratory diseases. 1996 J. Vet. Med. Sci. pmid:8877979
Katoh T et al. Effect of a combination of antimicrobial agents for the treatment of respiratory disease in cattle. 1996 J. Vet. Med. Sci. pmid:8877980
Inamoto T et al. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine. 1994 J. Vet. Med. Sci. pmid:7865594
Kobayashi H et al. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents. 1996 J. Vet. Med. Sci. pmid:8959659
Kim MH et al. Comparative pharmacokinetics of tylosin or florfenicol after a single intramuscular administration at two different doses of tylosin-florfenicol combination in pigs. 2008 J. Vet. Med. Sci. pmid:18250580
Clark C et al. Pharmacokinetics of tilmicosin in equine tissues and plasma. 2008 J. Vet. Pharmacol. Ther. pmid:18177321
Elitok B and Elitok OM Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease. 2004 J. Vet. Pharmacol. Ther. pmid:15500569
Clark C et al. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. 2004 J. Vet. Pharmacol. Ther. pmid:15500580
Fajt VR et al. Effects of danofloxacin and tilmicosin on circulating neutrophils in beef heifers. 2000 J. Vet. Pharmacol. Ther. pmid:11110107
Ziv G et al. Disposition kinetics of tylosin tartrate administered intravenously and intramuscularly to normal and water-deprived camels. 1995 J. Vet. Pharmacol. Ther. pmid:8583543
Ziv G et al. Tilmicosin antibacterial activity and pharmacokinetics in cows. 1995 J. Vet. Pharmacol. Ther. pmid:8587151
Brown SA et al. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice. 1995 J. Vet. Pharmacol. Ther. pmid:8587160
Dieste-Pérez L et al. Studies on a suitable antibiotic therapy for treating swine brucellosis. 2015 J. Vet. Pharmacol. Ther. pmid:25413993
Womble A et al. Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. 2006 J. Vet. Pharmacol. Ther. pmid:17083461
Canning P et al. Concentrations of tylvalosin and 3-O-acetyltylosin attained in the synovial fluid of swine after administration by oral gavage at 50 and 5 mg/kg. 2016 J. Vet. Pharmacol. Ther. pmid:27086612
Ling Z et al. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles. 2017 J. Vet. Pharmacol. Ther. pmid:27687707
Rose M et al. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. 2013 J. Vet. Pharmacol. Ther. pmid:22500881
Cerdá RO et al. Impact of the type of catheter on the absorption of tylvalosin (acetylvaleryltylosin) administered orally to broiler chickens. 2010 J. Vet. Pharmacol. Ther. pmid:20444046
Thomas E et al. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. 2001 J. Vet. Pharmacol. Ther. pmid:11696086
Foster DM et al. Comparison of direct sampling and brochoalveolar lavage for determining active drug concentrations in the pulmonary epithelial lining fluid of calves injected with enrofloxacin or tilmicosin. 2017 J. Vet. Pharmacol. Ther. pmid:28457009